National Medical Products Administration

The National Medical Products Administration (NMPA) is China's national regulatory authority for medical products, including drugs, medical devices, and cosmetics. In elsewhere's corpus, it appears primarily as the approval body for innovative medical devices seeking market access in China.

Per Gaorong Ventures' reporting, NMPA granted approval for Pulnovo Medical's PADN catheter, making it China's first First-in-Class original pulmonary hypertension medical device . The agency's review process and approvals are treated as significant milestones for domestic medtech companies aiming to commercialize breakthrough therapies. elsewhere's coverage does not extend to NMPA's organizational structure, history, or broader regulatory framework beyond these product-level approval moments.